Nutex Health (NUTX) Long-Term Deferred Tax (2020 - 2025)

Nutex Health has disclosed Long-Term Deferred Tax across 5 years of filings, most recently posting $12.9 million for Q2 2025.

• Long-Term Deferred Tax for Q2 2025 came in at $12.9 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $12.9 million (changed N/A YoY), and the FY2024 annual result was $8.0 million, changed N/A from the prior year.
• Long-Term Deferred Tax came in at $12.9 million for Q2 2025 at Nutex Health, up from $10.5 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $12.9 million in Q2 2025 to a low of $2.4 million in Q3 2022.
• The 4-year median for Long-Term Deferred Tax is $2.4 million (2021), against an average of $5.0 million.
• Across the five-year window, Long-Term Deferred Tax jumped 99.8% in 2021 and plunged 38.53% in 2022, its largest moves.
• Nutex Health's Long-Term Deferred Tax stood at $3.9 million in 2021, then plunged by 38.53% to $2.4 million in 2022, then soared by 232.79% to $8.0 million in 2024, then jumped by 60.91% to $12.9 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $12.9 million (Q2 2025), $10.5 million (Q1 2025), and $8.0 million (Q4 2024), per Business Quant data.